alexa Enhancing Translational Potential Of Mesenchymal Stem Cell (MSC) Therapies For Cancer With 3D Culture
ISSN: 2157-7552

Journal of Tissue Science & Engineering
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

Global Congress on Tissue Engineering, Regenerative & Precision Medicine
December 1-2, 2016 | San Antonio, USA

Thomas Bartosh
Texas A&M University Health Science Center, USA
Keynote: J Tissue Sci Eng
DOI: 10.4172/2157-7552.C1.029
Abstract
Mesenchymal stem cells (MSCs) have many potential applications in cancer therapy and regenerative medicine. In particular, there is interest in exploiting the notable tumor-tropic properties of MSCs to deliver suicide genes directly into tumors. Recently, we prepared a standardized bank of iPS cell-derived MSCs (iPSC-MSCs) engineered to stably express the suicide gene that codes for cytosine deaminase (CD), an enzyme that converts the inert prodrug 5-fluorocytosine (5-FC) into the cytotoxic agent 5-fluorouracil (5-FU). These genetically modified cells constitutively expressed high levels of CD through numerous passages and following cryopreservation and maintained features characteristic of tissue-derived MSCs. IPSC-MSCs expressing CD showed robust bystander activity and dose-dependent killing of all cancer cell lines tested in vitro and/or in vivo in the presence of 5-FC. The translational potential of MSC-based therapies for cancer has been hindered by low cell viability and microvascular entrapment following intravenous injection. Here we showed that when CD-expressing iPSC-MSCs were prepared as multicellular spheroids in 3D hanging drop cultures, cell size was markedly reduced similar to tissue-derived MSCs and cell resiliency was improved. Apparently as a result, greater numbers of viable cells were able to avoid obstructing lung microvasculature following tail vein injection in mice. As expected, lung inflammation was less severe following intravenous injection of the cells from 3D cultures versus cells prepared in standard adherent 2D cultures. Interestingly, expression of CD, as well as the anti-cancer factor TRAIL, was augmented in the sphere-derived iPSC-MSCs. CD-expression was also augmented in extracellular vesicles (EVs) derived 3D cultures, relative to 2D cultures. Remarkable anti-tumor effects of the CD-expressing iPSC-MSCs and EVs from 3D cultures were observed in vitro as well as in a human breast cancer xenograft model with and without 5-FC treatment. Importantly, activation of the prodrug also resulted in elimination of the modified iPSC-MSCs thus providing a safeguard against wayward stem cell progeny. Taken together, the results here provide evidence that iPSC-MSCs from 3D cultures have immense translational potential as cellular carriers of therapeutic transgenes and in precision medicine.
Biography

Thomas Bartosh has completed his PhD degree in Cell Biology and Genetics from The University of North Texas Health Science Center, USA. He has joined the Institute for Regenerative Medicine (IRM) at Texas A&M University in 2008 to develop therapies with mesenchymal stem cells (MSCs). He is currently an Assistant Professor of Medical Physiology in the College of Medicine at Texas A&M University. He studies the advantages of using three-dimensional (3D) culture methods to activate MSCs and exploit their inherent therapeutic potential.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords